Drug profile · INN
tranexamic acid
APO-TRANEXAMIC ACID
tranexamic acid (APO-TRANEXAMIC ACID) is a plasminogen inhibitor. Associated with Pfizer Australia Pty Ltd. Route of administration: injection. Current US regulatory status: approved.
Drug details — tranexamic acid
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 18
- Data quality
- 0.89
Quick answer
tranexamic acid (APO-TRANEXAMIC ACID) is a plasminogen inhibitor. Associated with Pfizer Australia Pty Ltd. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Plasminogen inhibitor
Primary target: Plasminogen
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| TGA | approved | — |
Recent coverage
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is tranexamic acid?
tranexamic acid (APO-TRANEXAMIC ACID) is a plasminogen inhibitor. Associated with Pfizer Australia Pty Ltd. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for tranexamic acid?
APO-TRANEXAMIC ACID is a marketed brand name for tranexamic acid. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of tranexamic acid?
tranexamic acid has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.